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Background: Surgical treatment for varicose recurrence (STVR) involves removing all sources of reflux from the deep venous
network to the superficial venous network. STVR is usually more complex and aggressive than first-line treatment by stripping,
particularly for redo surgery at the groin (RSG). This retrospective study compared traditional STVR and a less aggressive
surgical approach focusing on treatment of the varicose reservoir and avoiding RSG if possible.
Method: Two successive periods of STVR after great saphenous vein stripping were compared: traditional STVR (T1) and
STVR focusing on the varicose reservoir (T2). We reviewed postoperative complications and studied the hemodynamic
and clinical results.
Results: During T1 and T2, we operated 473 legs in 288 patients (236 women, 52 men) to treat varicose recurrence after
great saphenous vein stripping. Mean age was 60.83 years (range, 28-88 years). We operated on 137 patients during T1
and 151 during T2. Patients had similar demographic data, CEAP classification, and Venous Disability Score. Inguinal
reflux occurred in 73.9% of T1 patients and in 74.4% of T2 patients. We performed RSG in 66.0% of T1 patients and in
2.2% of T2 patients (P < .05). We did not use echo-guided sclerotherapy in addition to primary STVR. Tumescent local
anesthesia was used in 96.2% of STVR in T2 vs 4.0% in T1 (P < .05), and 95.3% of T2 procedures were outpatient vs
13.7% of T1 (P < .05). Outcomes of limbs presenting an inguinal reflux treated with RSG during T1 (group 1) and
without RSG during T2 (group 2) were compared. Postoperative complications occurred in 6.7% in group 1 vs 0.5% in
group 2 (P < .05), with inguinal complications predominating. The mean cost of the procedure per limb was €1,195.88
in group 1 vs €863.08 in group 2 (P< .0001). After 3 years of follow-up, Kaplan-Meier life-table analysis showed group
1 and 2 patients had similar rates of freedom from inguinal reflux (90.8% vs 92.9% survival rate) and from varicose
repeat-recurrence (90.8% vs 91.9% survival rate). Group 1 had better results for the Venous Disability Score (0.38 vs
0.58, P  .02) and cosmetic improvement (94.2% vs 84.2%; P  .00032).
Conclusion: STVR focusing on the varicose reservoir and avoiding RSG led to a minimally invasive procedure and a reduction
in postoperative complications, with good medium-term clinical and hemodynamic results, particularly for symptoms
improvement and cosmetic appearance, with a lower cost vs traditional STVR with RSG. (J Vasc Surg 2010;51:1442-50.)Varicose recurrence after surgical varices treatment is
common, but its frequency varies in the literature between
6% and 93% depending on the authors, the length of
follow-up, and the evaluation method.1-7 Nevertheless,
surgical treatment for varicose recurrence (STVR) repre-
sents about 20% of surgical varices treatment,8-11 making it
a common procedure for a vascular surgeon.
STVR traditionally involves removing all sources and
paths of reflux from thedeep venous network to the superficial
venous network.12-16 This approach is based on the descend-
ing physiopathologic theory of varicose disease17,18 that ex-
plains recurrence by the reopening of points of reflux starting
from the deep venous network, at the old saphenous conflu-
ence or perforator veins, leading to the formation of new
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1442varices.3,10,15,19,20 STVR is generally more complex and ag-
gressive than first-line treatment bymeans of stripping, partic-
ularly for redo surgery at the groin (RSG).14,21-24 Indeed, the
traditional STVR can associate RSG for treating a recurrent
reflux at the saphenous confluence, with the ligation of reflux-
ing perforators, the ablation of residual or recurrent incompe-
tent saphenous trunk, and the ablation of varices by phlebec-
tomy, depending on the hemodynamic and clinical situation.
The appearance of an ascending concept of varicose
disease, describing an initial evolution starting from the
suprafascial venous network,25-29 has led to treatment fo-
cusing on the varicose reservoir.30-32 Surgical treatment for
“sources” of reflux can therefore be questioned, especially
when it is aggressive and requires a redo surgery on scar
tissue. The goal of this study was to compare the results
of traditional STVR with the results of a more recent, less
aggressive, minimally invasive surgical approach focusing
on treatment of the varicose reservoir, avoiding RSG as
often as possible and trying to limit the surgery at
phlebectomy.
MATERIALS AND METHODS
This retrospective study was conducted at two surgical
centers: the Riviera Veine Institut in Nice, France, and the
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patients were operated on by two surgeons (P. P. and S. C.)
in both centers, the surgeons having the same activity in
terms of volume and techniques used in both facilities. The
patients included underwent STVR for recurrence after
crossectomy and stripping of the great saphenous vein
(GSV) between January 1998 and December 2005.
Preoperative data. Preoperative data were collected
for age, gender, CEAP class C, the presence of symptoms
(pain, heaviness, a swelling sensation, pruritus, night
cramps, restlessness, tingling, heat) regardless of their loca-
tion on the limb, and their repercussions according to the
Venous Disability Score (VDS).33 The hemodynamic and
anatomic data were recorded by duplex ultrasound (DUS)
examination.
The DUS examination was performed with the patient
standing upright. The reflux was evaluated by DUS scan-
ning of the deep venous network, the saphenofemoral
confluence, perforator veins, residual intrafascial saphenous
trunks, and suprafascial collaterals by using the manual
venous flushing maneuver in the calf region (calf compres-
sion). The reflux was recorded at themoment of the sudden
release of manual compression of the calf and was consid-
ered to be pathologic if the reflux duration0.5 second for
the superficial veins and 1 second for the whole deep
veins above and below the knee. A pathologic refluxing
perforator was defined as a perforator vein with a reflux
0.5 second, a diameter of 3 mm, and in connection
with varices. The reflux duration was measured with 0.1-
second accuracy. The measurement was done by the same
operator in each facility (T.L. inNice andO.R. inMonaco).
We reviewed the preoperative mapping, and the extent
of the varices was determined according to the number of
zones to be treated, with each limb divided into 32 zones in
the same manner that we have already reported.32
Surgical procedures. We also studied the surgical
variables of performance of RSG, operation time, method
of anesthesia, and type of hospitalization. The costs of the
procedures were calculated according to the reimburse-
ment of medical fees and hospitalization expenses by the
insurance companies for each patient.
Follow-up. The out-of-work time prescribed was sys-
tematically recorded in themedical file of patients whowere
employed. As specified by the protocol of follow-up sys-
tematically applied in the two centers participating in the
study, the patients were seen postoperatively at 1 and 6
months and then once yearly for the evaluations of postop-
erative complications, the presence of repeat-recurrent var-
icose veins according to the Recurrent Varices After Sur-
gery (REVAS) criteria,34 the presence and evolution of the
symptoms according to the patient questionnaire (relief,
unchanged, or worse) and according to the VDS, hemody-
namics using Doppler US imaging in the same way as
preoperatively, aesthetic results according to the patient
questionnaire (improved, unchanged, or worse), and fi-
nally, the performance of secondary procedures (surgery or
echo-guided sclerotherapy) for repeat recurrences on the
operated area.Periods studied. We compared two successive periods
during this retrospective study: the first (T1) was January
1998 to December 2002, when traditional STVR was
performed; and the second (T2) was from January 2003 to
December 2006, when minimally invasive STVR focusing
on the varicose reservoir was adopted. We excluded from
the study medical records for which we could not retro-
spectively find all of the clinical and hemodynamic data as
mentioned.
Statistical analysis. The means for continuous vari-
ables were calculated with a standard deviation threshold of
 0.05. The qualitative bivariate comparisons used the 2
test, and the means comparisons used the t test. Midterm
survival curves were determined using Kaplan-Meier life-
table analysis. The Kaplan-Meier life-table analysis compar-
isons used the log-rank test. Statistical analysis was per-
formed using Epi info (Centers for Disease Control and
Prevention, Atlanta, Ga) and XLSTAT software (Addinsoft
France, Paris, France). The significance level for all of the
comparisons was set at P  .05.
RESULTS
Population. During the retrospective period of T1
and T2, we performed 2146 procedures for lower limb
varices, including 456 (21%) for varicose recurrence after
crossectomy and stripping (CS) of the saphenous vein,
comprising 435 after CS of the GSV, 16 after CS of the
small saphenous vein (SSV), and 22 after CS of the GSV
and SSV combined. The medical files were not suitable
for research use in 47 of the 435 cases of STVR after CS
of the GSV because 22 were lost to follow-up during T1
and 25 during T2. The STVR procedures that were lost
to follow-up comprised RSG plus phlebectomy in 14
patients (all during T1) and isolated phlebectomy in 33
(8 cases during T1 and 25 cases during T2).
Among the 388 medical files that were complete for
follow-up, we operated on 473 limbs (244 by P.P., 229 by
S.C.) in 288 patients (149 by P.P., 139 by S.C.), consisting
of 236 women and 52 men who were a mean age of 60.83
1.44 years (range, 28 to 88 years). We operated on 137
patients (71 by P.P., 66 by S.C.) comprising 175 procedures
in 203 limbs during T1 and 151 patients (78 by P.P., 73 by
S.C.) comprising 213 procedures in 270 limbs during T2.
The T1 and T2 patients were not significantly different in
preoperative demographic data, symptom frequency,
CEAP class, and the VDS (Table I). A comparison of the
reflux typology, particularly sources of reflux, did not
reveal any difference between T1 and T2 patients, with a
high frequency of inguinal reflux and pathologic reflux-
ing perforators (Table II).
Procedures performed. A comparison of the charac-
teristics of STVR procedures showed a significant differ-
ence between T1 and T2 for the performance of RSG,
which was more common during T1 (66.0% vs 2.2% P 
.05) and for mean operation time, which was longer during
T1 (53.54  2.34 vs 42.50  2.28 minutes, P  .0001;
Table III). Six cases required RSG during T2 because of a
thrombosis of a cavernoma at the groin in 3, the presence of
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mm in 1. Echo-guided sclerotherapywas not used in any cases
as a complement during T1 or T2, particularly inguinally.
Anesthesia. The method of anesthesia differed signif-
icantly between periods T1 and T2, particularly for tumes-
cent local anesthesia (TLA), which was used in only 4.0% of
cases during T1 but in 96.25% during T2 (P  .05; Table
III). RSG required a general or locoregional anesthesia and
at least an overnight stay at the hospital in the 134 cases
done during T1 and in the 6 cases done during T2. There-
fore, there was a major significant difference between the
two periods in terms of the type of hospitalization: outpa-
tient in only 13.7% of cases during T1 but in 95.3% of cases
during T2 (P  .05; Table III).
To have two homogeneous groups for comparing the
outcomes, we discerned two cohorts among the patients
studied who had an inguinal reflux:
● Group 1 comprised the 106 patients (134 limbs) op-
erated on during T1 with RSG.
● Group 2 comprised the 109 patients (195 limbs) op-
Table I. Comparison of cohorts who underwent surgical
treatment for varices recurrence during T1 and T2
Variable T1a T2a
Patients, No. 137 151
Limbs, No. 203 270
Age, y
Mean  SD 60.85  2.24 60.80  1.85
Range 28-88 29-88
Female, % 83.20 80.80
CEAP classification, %
C0-C1 0 0
C2 85.20 85.20
C3 7.90 7.40
C4-C6 6.90 7.40
Limbs with symptoms, % 69.50 70.40
VDS, mean  SD 1.16  0.06 1.15  0.05
SD, Standard deviation; VDS, Venus Disability Score.
aTI: January 1998 to December 2002; T2: January 2003 to December
2006. P values for comparisons between groups were not significant.
Table II. Comparison of superficial reflux origin for
cohorts who underwent surgical treatment for varicose
recurrence during T1 and T2
Variable T1,a % T2,a %
Deep venous refluxb 0 0
Persistent saphenofemoral confluence 39.40 38.50
Inguinal neovascularization 34.50 35.90
Total inguinal reflux 73.90 74.40
Refluxing perforator(s), diameter 3 mm
Above the knee 19.20 20.40
Below the knee 55.20 54.10
More than one origin 64.50 64.10
Unknown 6.90 7.40
aT1: January 1998 to December 2002; T2: January 2003 to December
2006; P values for comparisons between groups were not significant.
bDefined as 1 second above and below the knee.erated on during T2 without RSG.Cost of procedures. A calculation of the cost of the
surgical procedures revealed a significant difference be-
tween group 1 and group 2, essentially because of the
method of anesthesia used and the type of hospitalization,
knowing that the fees reimbursed by insurance companies
remained the same throughout the period of the study (T1
and T2): €160,248 for the 134 limbs of group 1 performed
during T1 compared with €168,300 for the 195 limbs of
group 2 performed during T2, representing amean cost per
limb treated of €1195.88  5.69 for group 1 compared
with €863.08  2.90 for group 2 (P  .0001).
Postoperative complications. Group 1 had more
postoperative complications than group 2 (6.7% vs 0.5%;
P  .05), primarily because of the seven inguinal compli-
cations in group 1 vs none in group 2 (Table IV).
Time until return to work. Time until return to work
was highly significantly different for group 1 compared
with group 2: 20.57  1.40 vs 3.81  .67 days (P 
00001). The time until return to work was 8 days in
11.2% of group 1 compared with 91.7% for group 2 (P 
05), in which 43% of patients were able to return to work
the same day or the day after surgery (Table V).
Hemodynamic and clinical evolution. Absence of
Table III. Comparison of characteristics of surgical
treatment for varicose recurrence procedures for cohorts
operated on during T1 and T2
Variable T1a T2a P
Interventions, No. 175 213
Limbs, No. 203 270
Zones to be treated,
No.
Mean  SD 6.37  0.22 6.23  0.19 .297
Range 1-10 3-12
Redo surgery at the
groin, % limbs 66.00 2.20 .05
Incisions for
phlebectomy, No.
Mean  SD 31.87  1.99 30.60  1.82 .346
Range 4-67 10-56
Intervention duration,
min
Mean  SD 53.54  2.34 42.50  2.28 .0001
Range 10-95 10-80
Anesthetic procedure, %
interventions
General anesthesia 22.90 1.40 .05
Locoregional
anesthesia
(epidural) 71.40 2.35 .05
Nerve block 1.70 0 .05
Tumescent local
anesthesia 4.00 96.25 .05
Hospitalization, %
interventions
One night at least 86.30 4.70 .05
Outpatient 13.70 95.30 .05
SD, Standard deviation.
aT1: January 1998 to December 2002; T2: January 2003 to December
2006.inguinal reflux after 6 months and after 1, 2, and 3 years of
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99.2%, 96.0%, and 90.8% for group 1 and 97.9%, 96.8%,
94.7%, and 92.9% for group 2, respectively. The difference
between T1 and T2 was not significant (P.607, log-rank
test; Fig 1).
The characteristics of persistent or recurrent inguinal
reflux observed throughout the follow-up are described in
Table VI and are identical for both groups. No deep reflux
was observed in either group during the follow-up.
Freedom of varicose repeat-recurrence by Kaplan-
Meier life-table analysis at 6 months and at 1, 2, and 3 years
of follow-up was 99.2%, 98.5%, 96.1%, and 90.8% for
group 1 and 99.5%, 98.9%, 96.8%, and 91.9% for group 2,
respectively; there was no significant difference between the
groups (P  .738 log-rank test). Throughout the follow-
up, we observed repeat-recurrent varicose veins in 11 cases
during T1 and in 14 cases during T2. The sources of
repeat-recurrence were identical and independent of ingui-
nal reflux in most cases for both groups (Table VII).
The proportion of the 226 limbs with inguinal reflux
symptomatic before surgery that showed symptoms im-
provement after 6months and then after 1, 2, and 3 years of
follow-up by Kaplan-Meier life-table analysis was 98.9%,
Table IV. Postoperative complications after surgical
treatment for varicose recurrence for group 1 and for
group 2a
Variable
Group 1 Group 2
PNo. (%) No. (%)
Limbs operated on 134 195 ...
Inguinal lymphocele 4 0 ...
Inguinal lymphorrhea 3 0 ...
Deep venous thrombosis 1 0 ...
Delayed healing on limb incision 1 1 ...
Other 0 0 ...
Total complications 9 (6.7) 1 (0.5) .05
aGroup 1 was operated on during T1 (January 1998 to December 2002)
with redo surgery at the groin; group 2 was operated on during T2 (January
2003 to December 2006) without redo surgery at the groin.
Table V. Distribution of patients by time until return to
work after surgical treatment for varicose recurrence for
group 1 and group 2a
Variable
Group 1 Group 2
PNo. (%) No. (%)
Working patients 89 93
Same day or 1 day post-op 3 (3.4) 40 (43.0) .05
Days post-op
1-4 3 (3.4) 16 (17.2) .05
5-7 4 (4.5) 28 (30.1) .05
8-15 13 (14.6) 9 (9.7) .05
16-21 32 (36.0) 0 (0) ...
21 34 (38.2) 0 (0) ...
aGroup 1 was operated on during T1 (January 1998 to December 2002)
with redo surgery at the groin; group 2 was operated on during T2 (January
2003 to December 2006) without redo surgery at the groin.95.4%, 87.2%, and 76.5% for T1 and 99.3%, 99.3%, 96.9%,and 91.7% for T2, respectively. There was a significant
difference in favor of T2 (P  .0016; Fig 2).
The VDS assessment ranges from 0 (asymptomatic) to
3 (unable to perform normal activities even with compres-
sion and/or limb elevation). The change in mean VDS for
limbs with inguinal reflux symptomatic before surgery was
significantly reduced after 6 months from 1.17  0.07 to
0.53 0.13 (P .0001) for group 1 and from 1.20 0.06
to 0.35  0.08 for group 2. The mean VDS was signifi-
cantly higher after 6 months for group 1 compared with
group 2 (0.53  0.13 vs 0.35  0.08, P  .041) and
remained so throughout the follow-up period at 1 (0.55
0.13 vs 0.36 0.08; P  .031), 2 (0.59 0.13 vs 0.39
0.09; P .030), and 3 years (0.58 0.14 vs 0.38 0.09;
P  .02). The 134 limbs treated with RSG during T1 had
a significantly higher VDS than the 69 limbs treated
without RSG at 6 months (0.64  0.13 vs 0.35  0.10,
P  .02); and at 1 (0.63  0.13 vs 0.35  0.10, P  .04),
2 (0.64 0.13 vs 0.33 0.12, P .01;) and 3 years (0.63
 0.14 vs 0.34  0.12; P  .01), although this difference
did not exist preoperatively (0.81  0.08 vs 0.81  0.14;
P  .84). Meanwhile, general or locoregional anesthesia
was used for all limbs treated with RSG during T1 in
contrast to the limbs treated without RSG (100% vs 92%,
P  .05).
Esthetic improvements by Kaplan-Meier life-table anal-
ysis after 6 months and then after 1, 2, and 3 years of
follow-up were 98.5%, 96.9%, 89.9%, and 84.2% for group
1 and 99.5%, 98.9%, 97.3% and 94.2% for group 2, respec-
tively. There was a significant difference in favor of group 2
(P  .00032; Fig 3).
Additional procedures for repeat recurrences. We
performed new phlebectomies during the follow-up in two
limbs in group 1 and in three limbs in group 2. No repeat
RSG was performed during the follow-up in either group.
We performed echo-guided sclerotherapy at the saphe-
nofemoral confluence for persistent inguinal reflux during
the follow-up period in six cases in group 1 and in seven
cases in group 2.
Freedom of a secondary additional phlebectomy, RSG,
or echo-guided sclerotherapy after Kaplan-Meier life-table
analysis was 100.0%, 99.2%, 97.6%, and 93.2% for group 1
and 99.5%, 98.9%, 96.8%, and 94.3% for group 2, respec-
tively, at 6 months and at 1, 2 and 3 years. The difference
between group 1 and group 2 was not significant (P 
.747).
DISCUSSION
In the event of varicose recurrence after GSV stripping,
inguinal reflux recurrence is frequent in the form of a
genuine persistent saphenofemoral confluence or neovas-
cularization, which has been described increasingly fre-
quently in published reports.3-6 During the entire period
studied (T1 and T2), inguinal reflux was present in almost
three-quarters of the limbs treated for varicose recurrence
and in the form of neovascularization in half of the cases.
Surprisingly, we did not find any preoperative deep venous
reflux, probably because of the 1-second threshold chosen
bDefined as perforator, pelvic, abdominal, or other veins.
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below the knee.
Although the demographic and hemodynamic charac-
Fig 1. Kaplan-Meier analysis shows freedom from ingu
for varices recurrence. The blue curve represents limbs
operated on in group 2.
Table VI. Comparison of characteristics of iterative
inguinal reflux after surgical treatment for varicose
recurrence for group 1 and group 2a
Variable
Group 1 Group 2
No. (%) No. (%)
Persistent or recurrent SFC 4 (36.4) 5 (38.5)
Neovascularization 7 (63.6) 8 (61.5)
Total of iterative inguinal reflux 11 (100) 13 (100)
SFC, Saphenofemoral confluence.
aGroup 1 was operated on during T1 (January 1998 to December 2002)
with redo surgery at the groin; group 2 was operated on during T2 (January
2003 to December 2006) without redo surgery at the groin. P values for
comparisons were not significant.inal reflux (reflux duration  0.5 sec) after surgical treatment
operated on in group 1, and the red curve represents limbsteristics of the T1 and T2 populations were identical, weTable VII. Comparison of sources of varicose repeat
recurrence after surgical treatment for varicose recurrence
for group 1 and group 2a
Iterative varicose recurrence
Group 1 Group 2
No. (%) No. (%)
Connected to the SFC 4 (36.40) 5 (35.70)
Through AASV 3 3
Through MASV 1 2
Not connected to the SFCb 7 (63.40) 9 (64.30)
Total recurrence 11 14
AASV, Anterior accessory saphenous vein; MASV, medial accessory saphe-
nous vein; SFC, saphenofemoral confluence.
aGroup 1 was operated on during T1 (January 1998 to December 2002)
with redo surgery at the groin; group 2 was operated on during T2 (January
2003 to December 2006) without redo surgery at the groin. P values for
comparisons were not significant.
ed cu
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RSG in only 2.2% of cases compared with 66.0% during T1,
even though the proportion of inguinal reflux was the same
during T1 and T2 (73.9% vs 74.4%). This therefore repre-
sented a strategy change, with a minimally invasive treat-
ment focusing on varicose reservoir ablation, considering
that we could ignore the “inguinal source.”
Treatment during T2 was minimally invasive, with a
significantly shorter operation time of 42.50 vs 53.54 min-
utes, although the varicose extent treated was identical
during T1 and T2 (mean number of zones with varices to
be treated, 6.37 vs 6.23), and almost systematic TLA
(96.2%) compared with its rare use during T1 (4.0%). This
reduced level of surgical aggression enabled us to perform
the treatment on an outpatient basis in 95.1% during T2
compared with 13.7% during T1. Thus, not surprisingly,
we observed a significant saving on themean treatment cost
of €863.08 vs €1195.88 (P  .05), with an considerable
reduction of time until return to work of 20.57 days vs 3.81
days for limbs treated without RSG during T2 (group 2)
Fig 2. Kaplan-Meier analysis shows freedom from symp
curve represents limbs operated on in group 1, and the rcompared with RSG during T1 (group 1).Wenoted a significantly higher level of complications in
group 1 (6.7% vs 0.5% P .05), since three-quarters of the
complications were associated with the inguinal approach.
Our results confirmed the relatively aggressive nature of
RSG, the inguinal complications of which have been de-
scribed as being primarily lymphatic complications.21-24
The results for VDS at 6 months in favor of group 2 could
be explained by the negative influence of RSG for the
lymphatic and venous drainage of the limb; however, even
this hypothesis could not be confirmed in the absence of
precise data on symptoms during the follow-up.
The minimally invasive strategy adopted in group 2 was
no less effective in the midterm, with identical inguinal
reflux recurrence and persistency frequency and recurrent
varicose vein frequency throughout the follow-up periods
for group 1 and group 2, without the frequency of addi-
tional procedures being higher in group 2. The frequency
inguinal reflux recurrence and persistence after RSG is
rarely reported and varies widely from 12% at 19 months35
to 60% at 28 months36 of follow-up. The rate in our study
after surgical treatment for varices recurrence. The blue
rve represents limbs operated on in group 2.tomswas between 7.8% and 9.8% at 36 months.
ed cu
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with regard to symptoms improvement and aesthetics, per-
haps due to the minimally invasive nature of the treatment.
Meanwhile, it is difficult to determine postoperatively
whether RSG or the type of anesthesia was the most influ-
ential factor for the results between group 1 and group 2
because both factors changed concomitantly during both
periods. In our experience, however, RSG required the
choice of a general or locoregional anesthesia, including
during T2, where only the interventions with RSG were
performed under general anesthesia. Thus, the choice to
avoid RSG is likely the factor that led to the use of TLA in
96% during T2 and then to globally limiting the aggres-
siveness of the procedure.
It is actually difficult to explain retrospectively the
difference in cosmetic outcomes, especially at midterm.
Several explanations could be mentioned regarding the
redo surgery on scar tissue, including an unaesthetic post-
operative aspect of the scar at the groin or the appearance of
Fig 3. Kaplan-Meier analysis shows improvement of est
curve represents limbs operated on in group 1, and the rtelangiectasia or reticular veins around the groin or on thethigh. The reliability of the measurement of the cosmetic
outcomes can also be questioned because it was based only
on the patient’s self-assessment with a limited choice of
answers.
Our observations, with the precautions relating to a
retrospective study, could justify a minimally invasive ap-
proach to STVR and avoiding RSG, which causes most of
the complications. Furthermore, echo-guided foam sclero-
therapy is cited as first-line treatment for inguinal reflux
associated with varicose recurrence because of its minimally
invasive nature and efficacy.35-39 In contrast to the tradi-
tional approach for STVR that leads to the treatment of all
sources of reflux,12-16 our results could lead to focusing the
treatment on the ablation of the varicose reservoir and not
on the inguinal reflux, because the midterm results were
not worse for limbs with inguinal reflux not treated by
RSG, and no additional echo-guided inguinal sclerotherapy
was done.
The initial role played by inguinal reflux in the physiopa-
after surgical treatment for varices recurrence. The blue
rve represents limbs operated on in group 2.heticsthology of varicose recurrence could therefore be questioned,
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pathology of primary varices is contested.25-29 The frequency
of inguinal reflux associated with varicose recurrence in our
study conforms to reported figures,2-4,7-11 with a large
amount of neovascularization. Recent publications have
reported inguinal neovascularization as the main cause of
varicose recurrence40-42 whereas the main cause in older
publications was an inadequate initial operation with failure
to perform a flush saphenofemoral ligation with ligation
and division of all tributaries (so-called extensive crossec-
tomy), leaving a residual refluxing stump.1-3,15,19 Perfor-
mance of extensive crossectomy by most surgeons for al-
most 30 years has not reduced the frequency of procedures
for varicose recurrence, which remains about 20%,8-11,16
but has led to the appearance of a new “source” of varicose
recurrence, replacing the residual stump with neovascular-
ization. Furthermore, the performance of endovenous or
surgical ablation of the GSV with conservation of the
saphenofemoral confluence does not cause more varicose
recurrence in the medium term than when a crossectomy is
associated.43-45
It therefore now seems that the evolution of varicose
disease is the cause of most cases of postsurgical varicose
recurrence. We have already reported that the extent of the
varicose reservoir to be treated was the major prognostic
factor for varicose recurrence after the initial treatment of
primary varices,32 an extensive varicose reservoir indicating
the progressive or advanced nature of the varicose disease.
This progression could form part of the ascending or mul-
tifocal theory of development of varicose disease starting
from the suprafascial venous network, widely reported in
the literature for several years, for primary varices develop-
ment.25-29 This theory could explain how varicose recur-
rence develops once again from the suprafascial network,
constituting a refluxing reservoir with a filling effect re-
sponsible for reflux at the connections between the super-
ficial and deep networks (perforator veins, residual saphe-
nous confluences, and inguinal neovascularization).
We have previously reported this ascending venous
reflux progression and the disappearance of the saphenous
reflux by the suppression of the filling effect, after the
ablation of the varicose reservoir by phlebectomy.32 Thus,
as for minimally invasive surgical treatment that rejects
crossectomy and ablation of a refluxing saphenous vein,
STVR focusing on ablation of the varicose network could
enable the surgeon to be minimally invasive, thus avoiding
RSG whilst remaining at least as effective, as our midterm
results have shown. Thus, this approach enables the surgical
intervention to be competitive with foam sclerotherapy
thanks to its ability to treat varicose recurrence efficiently
with a gentle procedure and a simple postoperative course.
CONCLUSION
Minimally invasive STVR focusing on the varicose res-
ervoir and avoiding RSG has given good midterm clinical
and hemodynamic results, particularly for symptoms and
aesthetics, compared with traditional STVR with RSG,
without necessitatingmore frequent secondary procedures.Furthermore, minimally invasive STVR hasmade it possible
to use tumescent local anesthesia and treat most patients as
outpatients, with a significant reduction in postoperative
complications and in treatment costs. Longer-term follow-
up will be necessary to confirm the promising results of this
minimally invasive approach to STVR, and randomized
controlled trials are required to learn whether RSG is
mandatory.
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